Data Foundry

Drug recalls 2017

Benzonatate capsules — Class III drug recall D-0858-2017

Terminated recall by Strides Pharma INC, reported 2017-05-31, distributed nationwide. Failed Stability Specifications: Out of Specification results obtained for preservative Methylparaben content.

Recall numberD-0858-2017
Product typeDrug
ClassificationClass III
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmStrides Pharma INC, East Brunswick, NJ, United States
Recall initiated2017-05-09
Classified2017-05-23
Reported by FDA2017-05-31
Terminated2017-12-22
DistributedNationwide (US)
Quantity127,517 bottles
Reason classesspecification failure
NDC64380-0712, 64380-0712-06, 64380-0712-07, 64380-0713, 64380-0713-06, 64380-0713-07
Lot numbers7225075, 7225076, 7225077, 7225078, 7225079, 7225080, 7225180, 7225181, 7225322, 7225323, 7225649A, 7225650A, 7225651A, 7225652A, 7225653A, 7225654A
Expiration dates2017-07, 2017-08, 2017-09

Product

Benzonatate capsules, 200 mg, 100-count bottle, Rx only, Manufactured by: Strides Shasun Limited Bangaluru -560076 India, Distributed by Strides Pharma Inc East Brunswick, NJ 08816, NDC 64380-713-06

Reason for recall

Failed Stability Specifications: Out of Specification results obtained for preservative Methylparaben content.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0858-2017. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.